RVTY Competitors & Alternatives
Compare Revvity Inc. with similar stocks in the same industry
Diagnostics & Research
RVTY
Main Stock$124.75
Tradestie Score
50
Market Cap
$10.65B
P/E Ratio
56.2
Revenue Growth
0.0%
Analyst Upside
-3.0%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WAT
Waters Corp
|
$410.70
|
$19.04B | 105.4 | 51 | Compare |
|
ILMN
Illumina Inc
|
$219.40
|
$15.72B | 39.9 | 44 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$620.75
|
$15.28B | 36.0 | 48 | Compare |
|
ICLR
Icon Plc
|
$172.23
|
$14.96B | 264.0 | 44 | Compare |
|
EG
Everest Group, Ltd.
|
$370.06
|
$14.83B | 7.7 | 60 | Compare |
|
BALL
Ball Corporation
|
$63.59
|
$13.74B | 17.9 | 52 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
|
QGEN
QIAGEN N.V.
|
$44.07
|
$10.04B | 21.5 | 45 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$295.19
|
$8.39B | - | 35 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$170.69
|
$7.81B | - | 50 | Compare |
More RVTY Analysis
Data updated: Aug 23, 2026 | Industry: Diagnostics & Research (SIC 3826)
37 stocks in this industry